Home » Topics » Regulatory

Regulatory
RSS

Cephalosporin tested in Italian patients with ALS

Oct. 25, 1996

First and only Estrophasic oral contraceptive approved

Oct. 18, 1996

Serono's recombinant human growth hormone approved

Oct. 18, 1996

First low-dose hydrochlorothiazide product approvable

Oct. 18, 1996

Antihypertensive combination cleared for marketing in the U.S.

Oct. 18, 1996

First approval for Astra asthma product

Oct. 18, 1996

Schering-Plough's Claritin line expanded

Oct. 18, 1996

Dimethaid seeks approval for treatment for arthritic pain

Oct. 18, 1996

Improved formulation of Testoderm available in U.S.

Oct. 11, 1996

Muse approvable for treatment of impotence

Oct. 11, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.